Literature DB >> 34515053

Improved Dialysis Removal of Protein-Bound Uraemic Toxins with a Combined Displacement and Adsorption Technique.

Yuanyuan Shi1,2, Huajun Tian3, Yifeng Wang3, Yue Shen3, Qiuyu Zhu3, Feng Ding3.   

Abstract

INTRODUCTION: Protein-bound uraemic toxins (PBUTs) are poorly removed by conventional dialytic techniques, given their high plasma protein binding, and thus low, free (dialysable) plasma concentration. Here, we evaluated and compared PBUTs removal among conventional haemodialysis (HD), adsorption-based HD, displacement-based HD, and their 2 combinations both in vitro and in vivo.
METHODS: The removal of PBUTs, including 3-carboxy-4-methyl-5-propyl-2-furan-propanoic acid (CMPF), p-cresyl sulphate (PCS), indoxyl sulphate (IS), indole-3-acetic acid (3-IAA), and hippuric acid, was first evaluated in an in vitro single-pass HD model. Adsorption consisted of adding 40 g/L bovine serum albumin (Alb) to the dialysate and displacement involved infusing fatty acid (FA) mixtures predialyser. Then, uraemic rats were treated with either conventional HD, Alb-based HD, lipid emulsion infusion-based HD or their combination to calculate the reduction ratio (RR), and the total solute removal (TSR) of solutes after 4 h of therapy.
RESULTS: In vitro dialysis revealed that FAs infusion prefilter increased the removal of PCS, IS, and 3-IAA 3.23-fold, 3.01-fold, and 2.24-fold, respectively, compared with baseline and increased the fractional removal of CMPF from undetectable at baseline to 14.33 ± 0.24%, with a dialysis efficacy markedly superior to Alb dialysis. In vivo dialysis showed that ω-6 soybean oil-based lipid emulsion administration resulted in higher RRs and more TSRs for PCS, IS, and 3-IAA after 4-h HD than the control, and the corresponding TSR values for PCS and IS were also significantly increased compared to that of Alb dialysis. Finally, the highest dialysis efficacy for highly bound solute removal was always observed with their combination both in vitro and in vivo.
CONCLUSIONS: The concept of combined displacement- and adsorption-based dialysis may open up new avenues and possibilities in the field of dialysis to further enhance PBUTs removal in end-stage renal disease.
© 2021 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Adsorption technology; Displacer augmented dialysis technique; End-stage renal disease; Haemodialysis; Protein-bound uraemic toxins

Mesh:

Substances:

Year:  2021        PMID: 34515053      PMCID: PMC9227672          DOI: 10.1159/000518065

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   3.348


  54 in total

1.  Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate.

Authors:  Timothy W Meyer; John W T Peattie; Jared D Miller; Diana C Dinh; Natalie S Recht; Jason L Walther; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2007-01-24       Impact factor: 10.121

2.  Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.

Authors:  Suguru Yamamoto; Mami Sato; Yoko Sato; Takuya Wakamatsu; Yoshimitsu Takahashi; Akira Iguchi; Kentaro Omori; Yasushi Suzuki; Isei Ei; Yoshikatsu Kaneko; Shin Goto; Junichiro J Kazama; Fumitake Gejyo; Ichiei Narita
Journal:  Artif Organs       Date:  2017-07-13       Impact factor: 3.094

3.  Enhanced Removal of Protein-Bound Uremic Toxins Using Displacers: Road to Success?

Authors:  Wim Van Biesen; Sunny Eloot
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-06       Impact factor: 8.237

4.  Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.

Authors:  Jianping Li; Yingyi Wang; Xuejun Xu; Wenjuan Cao; Zhiqiang Shen; Nan Wang; Jing Leng; Ning Zou; Erxin Shang; Zhenhua Zhu; Jianming Guo; Jinao Duan
Journal:  Phytomedicine       Date:  2018-12-16       Impact factor: 5.340

5.  Zirconium-Based Metal-Organic Frameworks for the Removal of Protein-Bound Uremic Toxin from Human Serum Albumin.

Authors:  Satoshi Kato; Ken-Ichi Otake; Haoyuan Chen; Isil Akpinar; Cassandra T Buru; Timur Islamoglu; Randall Q Snurr; Omar K Farha
Journal:  J Am Chem Soc       Date:  2019-02-01       Impact factor: 15.419

6.  Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial.

Authors:  Frank J-G Luo; Kajal P Patel; Ilian O Marquez; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  Am J Kidney Dis       Date:  2009-04-25       Impact factor: 8.860

7.  Haemodiafiltration at increased plasma ionic strength for improved protein-bound toxin removal.

Authors:  D H Krieter; E Devine; T Körner; M Rüth; C Wanner; M Raine; J Jankowski; H-D Lemke
Journal:  Acta Physiol (Oxf)       Date:  2016-06-22       Impact factor: 6.311

8.  Kinetics of saturated, monounsaturated, and polyunsaturated fatty acids in humans.

Authors:  Robert H Nelson; Manpreet S Mundi; Danielle T Vlazny; Almira Smailovic; Kalpana Muthusamy; Jaime P Almandoz; Ekta Singh; Michael D Jensen; John M Miles
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

Review 9.  p-Cresyl Sulfate.

Authors:  Tessa Gryp; Raymond Vanholder; Mario Vaneechoutte; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2017-01-29       Impact factor: 4.546

10.  Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study.

Authors:  Xia Tao; Stephan Thijssen; Peter Kotanko; Chih-Hu Ho; Michael Henrie; Eric Stroup; Garry Handelman
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

View more
  2 in total

1.  The Piezo1 hypothesis of renal anemia.

Authors:  Peter Kotanko; David J Jörg; Nadja Grobe; Christoph Zaba
Journal:  FASEB Bioadv       Date:  2022-05-25

Review 2.  Removal of Protein-Bound Uremic Toxins Using Binding Competitors in Hemodialysis: A Narrative Review.

Authors:  Vaibhav Maheshwari; Xia Tao; Stephan Thijssen; Peter Kotanko
Journal:  Toxins (Basel)       Date:  2021-09-04       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.